Venisect gives FDA additional data

17 Jun 2002

Venisect (Little Rock, AR), which is jointly developing an erbium-laser blood-drawing device with LaBarge (St. Louis, MO), has provided the FDA with additional information requested by the agency to complete its review of the Laser Lancet. Venisect conducted additional human clinical trials to gather information requested by the FDA.
Courtesy of Laser Focus World